Screener
Beam Therapeutics BEAM Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
FAQ
- What is Beam Therapeutics's net income?
- Beam Therapeutics (BEAM) reported net income of -$94.32M in Q1 2026.
- How has Beam Therapeutics's net income changed year-over-year?
- Beam Therapeutics's net income increased by 12.9% year-over-year, from -$108.33M to -$94.32M.
- What is the long-term trend for Beam Therapeutics's net income?
- Over 2 years (2021 to 2024), Beam Therapeutics's net income has grown at a 0.8% compound annual growth rate (CAGR), from -$370.64M to -$376.74M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Beam Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude